MINT-ONDANSETRON SOLUTION DIN 02524090
Status: Marketed
Holder: MINT PHARMACEUTICALS INC
Molecule: ONDANSETRON (ONDANSETRON HYDROCHLORIDE)
Available to quote
Health Canada record
| Active ingredient(s) | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG |
|---|---|
| Dosage form | Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A04AA01 ONDANSETRON |
| Original market date | 11-Sep-2024 |
| Current status date | 11-Sep-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Mint Pharmaceuticals Inc — licence 101613, currently licensed, last inspection rating C (2023-01-16).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ONDANSETRON (ONDANSETRON HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02304597 | IPG-ONDANSETRON | MARCAN PHARMACEUTICALS INC | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Approved |
| 02304600 | IPG-ONDANSETRON | MARCAN PHARMACEUTICALS INC | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Approved |
| 02556995 | JAMP ONDANSETRON TABLETS | JAMP PHARMA CORPORATION | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Approved |
| 02557002 | JAMP ONDANSETRON TABLETS | JAMP PHARMA CORPORATION | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Approved |
| 02313693 | JAMP-ONDANSETRON | JAMP PHARMA CORPORATION | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Marketed |
| 02313685 | JAMP-ONDANSETRON | JAMP PHARMA CORPORATION | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Marketed |
| 02371758 | MAR-ONDANSETRON | MARCAN PHARMACEUTICALS INC | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Marketed |
| 02371731 | MAR-ONDANSETRON | MARCAN PHARMACEUTICALS INC | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Marketed |
| 02305259 | MINT-ONDANSETRON | MINT PHARMACEUTICALS INC | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Marketed |
| 02305267 | MINT-ONDANSETRON | MINT PHARMACEUTICALS INC | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Marketed |
| 02565374 | NRA-ONDANSETRON | NORA PHARMA INC | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Approved |
| 02565366 | NRA-ONDANSETRON | NORA PHARMA INC | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Approved |
| 02369389 | AG-ONDANSETRON | ANGITA PHARMA INC. | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Cancelled Pre Market |
| 02369370 | AG-ONDANSETRON | ANGITA PHARMA INC. | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Cancelled Pre Market |
| 02445840 | BIO-ONDANSETRON | BIOMED PHARMA | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Cancelled Pre Market |
| 02445859 | BIO-ONDANSETRON | BIOMED PHARMA | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Cancelled Pre Market |
| 02306212 | ONDANSETRON-ODAN | ODAN LABORATORIESLTD | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Cancelled Post Market |
| 02306220 | ONDANSETRON-ODAN | ODAN LABORATORIESLTD | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Cancelled Post Market |
| 02445700 | PRIVA-ONDANSETRON | PHARMAPAR INC | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Cancelled Pre Market |
| 02445697 | PRIVA-ONDANSETRON | PHARMAPAR INC | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Cancelled Pre Market |
| 02312247 | RAN-ONDANSETRON | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Cancelled Post Market |
| 02312255 | RAN-ONDANSETRON | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Cancelled Post Market |
| 02370298 | RIVA-ONDANSETRON | LABORATOIRE RIVA INC. | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Cancelled Post Market |
| 02370301 | RIVA-ONDANSETRON | LABORATOIRE RIVA INC. | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Cancelled Post Market |
| 02376105 | SEPTA-ONDANSETRON | SEPTA PHARMACEUTICALS INC | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 8 MG | Dormant |
| 02376091 | SEPTA-ONDANSETRON | SEPTA PHARMACEUTICALS INC | Tablet | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) 4 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 27359 | 2022-01-10 | Abbreviated New Drug Submission (ANDS) |